These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23157419)

  • 1. Protein-polyanion interactions for the controlled release of monoclonal antibodies.
    Schweizer D; Schönhammer K; Jahn M; Göpferich A
    Biomacromolecules; 2013 Jan; 14(1):75-83. PubMed ID: 23157419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation.
    Schweizer D; Vostiar I; Heier A; Serno T; Schoenhammer K; Jahn M; Jones S; Piequet A; Beerli C; Gram H; Goepferich A
    J Control Release; 2013 Dec; 172(3):975-82. PubMed ID: 24140353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific interactions in high concentration antibody solutions resulting in high viscosity.
    Yadav S; Liu J; Shire SJ; Kalonia DS
    J Pharm Sci; 2010 Mar; 99(3):1152-68. PubMed ID: 19705420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody self-association, cluster formation, and rheology at high concentrations.
    Lilyestrom WG; Yadav S; Shire SJ; Scherer TM
    J Phys Chem B; 2013 May; 117(21):6373-84. PubMed ID: 23560896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogels of N-isopropylacrylamide copolymers with controlled release of a model protein.
    Milasinović N; Kalagasidis Krusić M; Knezević-Jugović Z; Filipović J
    Int J Pharm; 2010 Jan; 383(1-2):53-61. PubMed ID: 19747965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cosolute effects on the chemical potential and interactions of an IgG1 monoclonal antibody at high concentrations.
    Scherer TM
    J Phys Chem B; 2013 Feb; 117(8):2254-66. PubMed ID: 23330570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cross-linker on alginate matrix integrity and drug release.
    Ching AL; Liew CV; Heng PW; Chan LW
    Int J Pharm; 2008 May; 355(1-2):259-68. PubMed ID: 18272307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet.
    Imai T; Kawasaki C; Nishiyama T; Otagiri M
    Pharmazie; 2000 Mar; 55(3):218-22. PubMed ID: 10756544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cosolute-Protein Interactions in the Dissociation of Monoclonal Antibody Clusters.
    Scherer TM
    J Phys Chem B; 2015 Oct; 119(41):13027-38. PubMed ID: 26390096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution pH that minimizes self-association of three monoclonal antibodies is strongly dependent on ionic strength.
    Sule SV; Cheung JK; Antochshuk V; Bhalla AS; Narasimhan C; Blaisdell S; Shameem M; Tessier PM
    Mol Pharm; 2012 Apr; 9(4):744-51. PubMed ID: 22221144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipole-dipole interaction in antibody solutions: correlation with viscosity behavior at high concentration.
    Singh SN; Yadav S; Shire SJ; Kalonia DS
    Pharm Res; 2014 Sep; 31(9):2549-58. PubMed ID: 24639233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-buffering antibody formulations.
    Gokarn YR; Kras E; Nodgaard C; Dharmavaram V; Fesinmeyer RM; Hultgen H; Brych S; Remmele RL; Brems DN; Hershenson S
    J Pharm Sci; 2008 Aug; 97(8):3051-66. PubMed ID: 18023013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects in semidilute mixed solutions of alginate and lactose-modified chitosan (chitlac).
    Donati I; Haug IJ; Scarpa T; Borgogna M; Draget KI; Skjåk-Braek G; Paoletti S
    Biomacromolecules; 2007 Mar; 8(3):957-62. PubMed ID: 17300173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-activated ionic gelation of common biopolymers.
    Javvaji V; Baradwaj AG; Payne GF; Raghavan SR
    Langmuir; 2011 Oct; 27(20):12591-6. PubMed ID: 21800827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts.
    Bertram U; Bodmeier R
    Drug Dev Ind Pharm; 2012 Jun; 38(6):659-69. PubMed ID: 22537309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
    Wells LA; Sheardown H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
    George M; Abraham TE
    J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics.
    Chan AW; Neufeld RJ
    Biomaterials; 2010 Dec; 31(34):9040-7. PubMed ID: 20739057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.